AABB Clinical Practice Guidelines for RBC Transfusions The AABB has updated their clinical practice guidelines regarding RBC transfusion thresholds. The guidelines are based on data from 45… October 12, 2023
FDA Guidance for COVID-19 Convalescent Plasma to Remain in Effect During the public health emergency for COVID-19, the U.S. Food and Drug Administration (FDA) issued guidance for the use of… March 22, 2023
New Draft FDA Guidance to Reduce the Risk of HIV Transfusion-Transmission Using Individual Risk-Based Questions The U.S. FDA recently issued draft guidance to reduce the risk of HIV transfusion-transmission using individual risk-based questions instead of… January 31, 2023
Updated FDA Guidance to Reduce the Risk of Transfusion-Transmitted Malaria In April 2020, the U.S. Food and Drug Administration (FDA) issued four blood donor eligibility guidelines—including one for malaria—to help… December 13, 2022
Donor Deferral Recommendations for HIV Pre-exposure Prophylaxis In December 2021, the U.S. FDA approved injectable cabotegravir (Apretude) as pre-exposure prophylaxis (PrEP) to prevent HIV transmission. PrEP, post-exposure… September 14, 2022
Transfusion Guidelines for Major Hemorrhage Major hemorrhage is an emergency with significant morbidity and mortality. The British Society for Haematology (BSH) has updated transfusion guidelines… June 22, 2022
Updated FDA Guidance to Reduce Risk of Transmission of Creutzfeldt-Jakob Disease The U.S. Food and Drug Administration (FDA) has issued updated guidance to reduce the transfusion-related transmission risk of Creutzfeldt-Jakob disease… June 1, 2022
Updated Transfusion Guidelines for High-Risk Surgery Patients Patient blood management programs use a multimodal approach to conserve blood and simultaneously improve patient outcomes. Transfusion guidelines are central… February 16, 2022
Minimal Concerns for HIV in the US Blood Supply after FDA Revised Guidance In 2015, the U.S. FDA revised guidance for blood donor deferral of men who have sex with men (MSM) from… September 15, 2020
FDA Issues Emergency Use Authorization for COVID-19 Convalescent Plasma To increase access to COVID-19 convalescent plasma (CCP) use, President Trump, in conjunction with the U.S. FDA, announced Emergency Use… August 25, 2020